Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-23

Clinical Trial Update: Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)

View source ↗

Summary

A completed Adelphi disease-specific programme update for primary Sjögren's syndrome sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sjogren's Syndrome | Status: COMPLETED